The authors presume that this homeostasis is impaired in gastric tumors due to the negative regulation of SLCO2A1 and, consequently, the negative regulation of PGE2 degradation, resulting in the enhancement of PGE2 signaling and gastric tumorigenesis [53]. This evidence concerns the gene SLCO2A1 and gastric neoplasm.